We just received data on a new analyst forecast for $TVTX. Yigal Nochomovitz from Citigroup set a price target of 62.0 for TVTX.
To track analyst ratings and price targets for $TVTX, check out Quiver Quantitative's $TVTX forecast page.
Should you buy $TVTX?
Some analysts are better than others. To view the past performance of Citigroup, check out Quiver’s Analyst Ratings dashboard. You can also see Quiver’s Analyst Buys Strategy, which uses a proprietary method to track the companies being recommended by the top Wall Street analysts.
$TVTX Price Targets
Multiple analysts have issued price targets for $TVTX recently. We have seen 9 analysts offer price targets for $TVTX in the last 6 months, with a median target of $56.0.
Here are some recent targets:
- Laura Chico from Wedbush set a target price of $55.0 on 06/03/2026
- Yigal Nochomovitz from Citigroup set a target price of $62.0 on 06/03/2026
- Joseph Pantginis from HC Wainwright & Co. set a target price of $67.0 on 06/02/2026
- Mohit Bansal from Wells Fargo set a target price of $50.0 on 05/06/2026
- Tyler Van Buren from TD Cowen set a target price of $60.0 on 05/05/2026
- Vamil Divan from Guggenheim set a target price of $56.0 on 04/24/2026
- Edward Nash from Canaccord Genuity set a target price of $56.0 on 04/14/2026
$TVTX Insider Trading Activity
$TVTX insiders have traded $TVTX stock on the open market 65 times in the past 6 months. Of those trades, 0 have been purchases and 65 have been sales.
Here’s a breakdown of recent trading of $TVTX stock by insiders over the last 6 months:
- ERIC M DUBE (CHIEF EXECUTIVE OFFICER) has made 0 purchases and 11 sales selling 366,587 shares for an estimated $12,315,905.
- ELIZABETH E REED (Chief Legal Officer and GC) has made 0 purchases and 15 sales selling 125,919 shares for an estimated $4,678,524.
- WILLIAM E. ROTE (Chief Research Officer) has made 0 purchases and 4 sales selling 84,309 shares for an estimated $3,292,432.
- JULA INRIG (CHIEF MEDICAL OFFICER) has made 0 purchases and 11 sales selling 56,929 shares for an estimated $2,370,109.
- ROY D. BAYNES has made 0 purchases and 5 sales selling 57,000 shares for an estimated $2,323,200.
- SANDRA CALVIN (SVP, CHIEF ACCOUNTING OFFICER) has made 0 purchases and 4 sales selling 36,622 shares for an estimated $1,442,611.
- PETER HEERMA (CHIEF COMMERCIAL OFFICER) has made 0 purchases and 4 sales selling 21,679 shares for an estimated $837,930.
- CHRISTOPHER R. CLINE (CHIEF FINANCIAL OFFICER) has made 0 purchases and 9 sales selling 19,805 shares for an estimated $753,123.
- JEFFREY A MECKLER sold 8,000 shares for an estimated $360,000
- GARY A LYONS sold 8,000 shares for an estimated $328,560
To track insider transactions, check out Quiver Quantitative's insider trading dashboard. You can access data on insider stock transactions through the Quiver Quantitative API insider transaction endpoint.
$TVTX Revenue
$TVTX had revenues of $127.2M in Q1 2026. This is an increase of 55.63% from the same period in the prior year.
You can track TVTX financials on Quiver Quantitative's TVTX stock page.
You can access data on TVTX stock through the Quiver Quantitative API.
$TVTX Hedge Fund Activity
We have seen 142 institutional investors add shares of $TVTX stock to their portfolio, and 169 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- MACQUARIE GROUP LTD removed 4,984,333 shares (-100.0%) from their portfolio in Q4 2025, for an estimated $190,451,363
- ADAGE CAPITAL PARTNERS GP, L.L.C. removed 2,575,000 shares (-72.5%) from their portfolio in Q1 2026, for an estimated $76,503,250
- FMR LLC added 1,350,104 shares (+14.0%) to their portfolio in Q1 2026, for an estimated $40,111,589
- ARMISTICE CAPITAL, LLC added 1,133,526 shares (+30.1%) to their portfolio in Q1 2026, for an estimated $33,677,057
- MPM BIOIMPACT LLC added 1,133,365 shares (+inf%) to their portfolio in Q1 2026, for an estimated $33,672,274
- MORGAN STANLEY removed 1,114,242 shares (-78.7%) from their portfolio in Q1 2026, for an estimated $33,104,129
- KYNAM CAPITAL MANAGEMENT, LP added 1,051,134 shares (+203.0%) to their portfolio in Q1 2026, for an estimated $31,229,191
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard. You can access data on hedge funds moves and 13F filings through the Quiver Quantitative API 13F endpoint.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information.
